Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
Atsushi Hosui, Takashi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu – 2 August 2021 – We have reported that the plasma zinc concentration gradually decreases with the progression of fibrosis and is related to hepatocellular carcinoma (HCC) development.